Written answers
Tuesday, 26 March 2019
Department of Health
Medicinal Products Reimbursement
Tommy Broughan (Dublin Bay North, Independent)
Link to this: Individually | In context | Oireachtas source
853. To ask the Minister for Health if patient advocacy groups will be included in the terms of reference for the mini-review by his Department of the drugs approval process here; and if he will make a statement on the matter. [13700/19]
Michael Healy-Rae (Kerry, Independent)
Link to this: Individually | In context | Oireachtas source
929. To ask the Minister for Health if patient groups (details supplied) will be included in the review of the drug approval process here; and if he will make a statement on the matter. [14108/19]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
I propose to take Questions Nos. 853 and 929 together.
My Department has completed a tender process for a review of the HSE reimbursement and pricing decision-making process and are currently appointing a consultancy firm to complete this review.
Although patients groups were not included in the terms of reference, consideration will be given to consultation with relevant stakeholders.
No comments